ALBERTAZZI, Alberto
 Distribuzione geografica
Continente #
NA - Nord America 13.219
EU - Europa 11.287
AS - Asia 5.359
SA - Sud America 727
AF - Africa 117
Continente sconosciuto - Info sul continente non disponibili 102
OC - Oceania 12
Totale 30.823
Nazione #
US - Stati Uniti d'America 12.909
IT - Italia 4.649
DE - Germania 2.608
CN - Cina 1.597
GB - Regno Unito 1.506
SG - Singapore 1.502
SE - Svezia 729
HK - Hong Kong 557
BR - Brasile 544
RU - Federazione Russa 533
VN - Vietnam 478
BD - Bangladesh 309
UA - Ucraina 248
FI - Finlandia 241
FR - Francia 220
KR - Corea 220
TR - Turchia 207
NL - Olanda 196
CA - Canada 178
IN - India 129
BG - Bulgaria 98
AR - Argentina 67
ID - Indonesia 49
MX - Messico 47
IQ - Iraq 45
JP - Giappone 42
MY - Malesia 42
ZA - Sudafrica 33
IE - Irlanda 28
ES - Italia 26
PK - Pakistan 26
CH - Svizzera 25
CO - Colombia 24
PL - Polonia 24
BE - Belgio 23
EC - Ecuador 23
RO - Romania 23
VE - Venezuela 21
AE - Emirati Arabi Uniti 19
CR - Costa Rica 18
MA - Marocco 18
TN - Tunisia 17
CL - Cile 16
AT - Austria 13
AZ - Azerbaigian 13
JM - Giamaica 13
PH - Filippine 13
PT - Portogallo 13
SA - Arabia Saudita 13
CZ - Repubblica Ceca 12
AU - Australia 11
DO - Repubblica Dominicana 11
DZ - Algeria 11
LT - Lituania 11
PE - Perù 11
AL - Albania 10
HN - Honduras 10
JO - Giordania 9
TH - Thailandia 9
DK - Danimarca 8
EU - Europa 8
IR - Iran 8
KE - Kenya 8
PY - Paraguay 8
TW - Taiwan 8
UZ - Uzbekistan 8
BB - Barbados 7
KZ - Kazakistan 7
BO - Bolivia 6
BY - Bielorussia 6
EG - Egitto 6
IL - Israele 6
UY - Uruguay 6
LB - Libano 5
MT - Malta 5
NP - Nepal 5
OM - Oman 5
RS - Serbia 5
TT - Trinidad e Tobago 5
HU - Ungheria 4
MD - Moldavia 4
PA - Panama 4
PS - Palestinian Territory 4
SY - Repubblica araba siriana 4
CY - Cipro 3
EE - Estonia 3
GE - Georgia 3
HR - Croazia 3
KG - Kirghizistan 3
NI - Nicaragua 3
NO - Norvegia 3
PR - Porto Rico 3
SI - Slovenia 3
AG - Antigua e Barbuda 2
AM - Armenia 2
AO - Angola 2
BH - Bahrain 2
BS - Bahamas 2
CW - ???statistics.table.value.countryCode.CW??? 2
ET - Etiopia 2
Totale 30.688
Città #
Ashburn 1.821
Santa Clara 1.149
Southend 1.059
Singapore 997
Fairfield 852
Hefei 657
Woodbridge 629
San Jose 601
Chandler 565
Hong Kong 551
Jacksonville 536
Houston 521
New York 490
Milan 459
Council Bluffs 348
Rome 345
Nyköping 343
Ann Arbor 342
Dearborn 338
Seattle 313
Wilmington 313
Cambridge 291
Dallas 257
Beijing 249
London 225
Seoul 195
Los Angeles 186
Chicago 170
The Dalles 161
Helsinki 154
Naples 152
Ho Chi Minh City 134
Izmir 108
Hanoi 106
Princeton 97
Modena 96
Sofia 94
Des Moines 89
Eugene 89
San Diego 82
São Paulo 77
Buffalo 74
Bari 71
Lauterbourg 71
Turin 70
Florence 65
Bologna 64
Moscow 58
Shanghai 53
Ottawa 51
Columbus 50
Salt Lake City 50
Toronto 49
Catania 46
Verona 39
Munich 38
Redwood City 35
Elk Grove Village 34
Genoa 34
Frankfurt am Main 33
Orem 33
Palermo 32
Tampa 32
Phoenix 30
Tokyo 30
Brescia 28
Falls Church 27
Livorno 26
Dublin 25
Guangzhou 24
Padova 24
Reggio Emilia 24
Jakarta 23
Montreal 23
Fremont 21
Philadelphia 21
Da Nang 20
Brooklyn 19
Brussels 19
Denver 19
Nanjing 19
Norwalk 19
Parma 19
Salerno 19
Venice 19
Kent 18
Lucca 18
Washington 18
Atlanta 17
Boardman 17
Cagliari 17
Johannesburg 17
Kunming 17
Baghdad 16
Leawood 16
Messina 16
Miami 16
Charlotte 15
Detroit 15
Haiphong 15
Totale 18.069
Nome #
Effetto della N-acetilcisteina sulla progressione dell'insufficienza renale cronica nel ratto 4.352
Effect of a continuous erythropoietin receptor activator (C.E.R.A.) on stable haemoglobin in patients with CKD on dialysis: Once monthly administration 670
Changes in conjugated linoleic acid and palmitoleic acid are correlated to retinol levels in chronic renal failure in both hemodialysis and conservative treatment patients 498
Relationship of asymmetric dimethylarginine to haemodialysis hypotension 483
Contrast-enhanced sonography in early kidney graft dysfunction. 467
Accuracy of eight-polar bioelectrical impedance analysis for the assessment of total and appendicular body composition in peritoneal dialysis patients 461
Comparison between hydroperoxides and malondialdehyde as markers of acute oxidative injury during hemodialysis 440
Plasma exchange in acute and chronic hyperviscosity syndrome: a rheological approach and guidelines study 433
Biofilms invade nephrology: effects in hemodialysis 418
Interstitial fluid obtained from kidney biopsy as new source of renal biomarkers 418
Changes in conjugated linoleic acid and its metabolites in patients with chronic renal failure 405
Activation of coagulation during hemodialysis: Effect of blood lines alone and whole extracorporeal circuit 404
Proteomic analysis of early urinary biomarkers of renal changes in type 2 diabetic patients 381
Comparison of the tubercolin skin test and the ellispot blood test for the diagnosis of latent tuberculosis infection in pre-transplant dialysis patients 379
Identification and characterization of a new autoimmune protein in membranous nephropathy by immunoscreening of a renal cDNA library 375
2-D proteomic analysis of urine in diabetic patients with nephropathy 368
A randomized trial of steroid avoidance in renal transplant patients treated with everolimus and cyclosporine 363
Il rene policistico autosomico dominante (ADPKD): aspetti genetico-molecolari, clinici ed epidemiologici nella provincia di Modena. 353
Clinical evaluation of internal hemodiafiltration (iHDF): A diffusive-convective technique performed with internal filtration enhanced high-flux dialyzers 348
Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis 347
Urinary protein profiling for biomarker discovery in diabetic nephropathy 346
“VITAMIN E MODULATES BENZOYL PEROXIDE TOXICITY IN HUMAN KERATINOCYTES” 342
I polimorfismi del gene dell’enzima di conversione dell’angiotensina (ACE) nel rene policistico autosomico dominante (ADPKD) 340
Liver and kidney foreign bodies granulomatosis in a patient with malocclusion, bruxism, and worn dental prostheses 330
Role of oxidative stress in progressive kidney failure 328
Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): A case report 327
L'organizzazione della chirurgia degli accessi vascolari: risultati di un questionario italiano 325
Pancreas Transplantation Inside Emilia-Romagna, Italy: Referral Pattern, Demand Forecasting, and Organ Availability 321
Antioxidants modulates benzoyl-peroxide toxicity in human keratinocytes 315
Ultrastructural features of polyethersulfone membranes 314
[Dyslipidemia and the risk of kidney disease]. 309
“Role of NO in hypotension prone dialytic patients” 309
Clinical Experience with PMMA Membrane 307
Multicenter Study on Double Kidney Transplantation 303
A validated model of disease progression in IgA nephropathy 299
Water treatment and monitor disinfection 299
Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments 298
Effects of biofilm formation on haemodialysis monitor disinfection 294
Influence of different hemodialysis membranes on red blood cell susceptibility to oxidative stress 292
Effect of alpha-tocopherol and N-acetylcysteine on benzoyl peroxide toxicity in human keratinocytes 291
Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease 291
Heparin and dialysis: reasons to make a change? 289
Autosomal dominant polycystic kidney disease: from genes to cilium. 289
Detection of type 2 diabetic nephropathy-associated biomarkers using proteomic tachniques 289
Hollow-Fiber Dialyzer Employing Vitamin E-Bonded Membrane: A Morphological Analysis 289
Markers urinari di nefropatia diabetica 288
Influence of ACE I/D gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease: a meta-analysis 286
Proteomic analysis of urine from proteinuric patients shows a proteolitic activity directed against albumin 286
Kidney preservation with university of Wisconsin and Celsior solution: A prospective multicenter randomized study. 277
The role of blood volume reduction in the genesis of intradialytic hypotension 275
Empoyment of the ELISPOT blood test for the diagnosis of latent tuberculosis infection in dialysis patients awaiting renal transplantation 273
Nitric oxide and hypotension in haemodialysis patients. 272
Which is the preferred vascular access in diabetic patients? A view from Europe 272
Trattato di Medicina Interna : Le Sindromi Renali. 271
Epidermal growth factor receptor polymorphism and autosomal dominant polycystic kidney disease 270
Management of vascular access for dialysis: an Italian survey. 269
Design of water treatment plants in the year 2000 and beyond 267
Water treatment for hemodialysis. 267
Early kidney-pancreas transplantation in type 1 diabetics prevents hemodialysis. 267
Water treatment for hemodialysis: a 2005 update 265
Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial. 265
Psychological factors associated with medication adherence following renal transplantation 263
Magnetic resonance in renal transplantation: Evaluation of post-surgery complications 260
Leukocyte adhesion molecules and leukocyte-platelet interactions during hemodialysis: effects of different synthetic membranes. 259
Screening of a kidney cDNA library for the identification of autoimmune proteins from serum of membranous nephropathy patients. 257
Human herpesvirus-8 infection in hemodialysis patients from northern Italy. 256
Primary IgA nephropathy is more severe in TGF-beta1 high secretor patients. 252
Interstitiome: a novel proteomic discipline applied to renal biopsy 251
Once-weekly epoetin-beta in renal anemia: the clinical evidence 248
Malignant neoplasia and kidney transplantation. Retrospective analysis of data on the population having kidney transplantation with de novo neoplasia in the setting of the AIRT 243
Biomarkers discovery of renal alterations in urine of diabetic patients by proteomic analysis 243
Screening of a kidney cDNA library for the identification of autoimmune proteins from serum of membranous nephropathy patients. 242
Retention of limulus amoebocyte lysate reactive bacterial products by polysulfone dialyzers is affected by the type of disinfectant. 240
Hemodialysis with Regenerated Cellulosic Membranes Does Not Reduce Plasma Selenium Levels in Chronic Uremic Patients. 237
MALATTIE DEL RENE, DELLE VIE URINARIE E DELL'APPARATO GENITALE MASCHILE : Le Nefropatie Glomerulari: glomerulonefriti primitive; glomerulonefriti secondarie 235
Tubercolosi linfonodale periferica in due pazienti in trattamento emodialitico cronico 235
Pyrogen Transfer across PMMA Membranes 235
Switching to lanthanum carbonate monotherapy provides effective phosphate control with a low tablet burden 234
Renal transplantation from "sub-optimal" donors: a clinico-morphological evaluation 231
Effetti della N-acetilcisteina in condizioni di stress ossidativo 230
Le alterazioni del volume e della composizione elettrolitica dei liquidi corporei. 224
Pazienti HCV+ in lista d'attesa per trapianto renale. Analisi retrospettiva dei dati relativi alla popolazione dei pazienti affetti da epatite C in lista d'attesa per trapianto di rene in ambito AIRT 223
Prospective study to evaluate efficacy and safety of basiliximab in combination with delayed administration of cyclosporine, MMF and steroids in recipients of grafts from marginal cadaver donors. 221
Geometria dell’anello di distribuzione e materiale utilizzato 216
Plasma antioxidants modifications during haemodialysis 202
Selenium in Uremia 158
No evidences of oxidative injury associated with slow intravenous administration of ferric gluconate during haemodialysis 156
Role of nitric oxide generating pathway in haemodialysis hypotension 153
Markers of oxidative stress and antioxidant status in haemodialysis patients 146
Reduced human lymphocyte blastogenesis and enhancement of adenosine triphosphate (ATP) by L-carnitine. 1
Effects of selenium supplementation on immune parameters in chronic uraemic patients on haemodialysis 1
L-carnitine enhances adenosine triphosphate (ATP) and inhibits lymphocyte proliferation. 1
Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. 1
Totale 30.823
Categoria #
all - tutte 93.014
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.014


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.261 0 0 0 282 30 60 103 70 172 84 279 181
2022/20232.430 194 220 161 200 199 396 121 232 273 111 191 132
2023/20242.446 109 125 187 219 298 251 343 240 115 171 154 234
2024/20255.010 293 236 201 395 933 715 393 251 437 167 484 505
2025/20267.162 493 318 803 689 895 612 758 383 699 547 621 344
2026/20272.809 205 837 675 1.092 0 0 0 0 0 0 0 0
Totale 30.823